Commonwealth Equity Services
PDSB icon

Commonwealth Equity Services’s PDS Biotechnology PDSB Stock Holding History

Commonwealth Equity Services’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.9K Sell
90,797
-106,000
-54% -$79.7K ﹤0.01% 4195
2025
Q4 		$151K Buy
196,797
+106,300
+117% +$95.9K ﹤0.01% 4040
2025
Q3 		$91K Sell
90,497
-175
-0.2% -$206 ﹤0.01% 4102
2025
Q2 		$121K Sell
90,672
-1,358
-1% -$1.84K ﹤0.01% 4031
2025
Q1 		$110K Buy
92,030
+14,305
+18% +$20.3K ﹤0.01% 3975
2024
Q4 		$127K Sell
77,725
-672
-0.9% -$1.78K ﹤0.01% 3865
2024
Q3 		$299K Sell
78,397
-530
-0.7% -$1.77K ﹤0.01% 3356
2024
Q2 		$231K Sell
78,927
-930
-1% -$2.98K ﹤0.01% 3532
2024
Q1 		$316K Buy
79,857
+2,850
+4% +$14.7K ﹤0.01% 3225
2023
Q4 		$383K Buy
77,007
+10,429
+16% +$51.8K ﹤0.01% 2957
2023
Q3 		$336K Buy
66,578
+3,025
+5% +$16.6K ﹤0.01% 2925
2023
Q2 		$320K Buy
63,553
+2,503
+4% +$16.4K ﹤0.01% 2996
2023
Q1 		$375 Buy
61,050
+50
+0.1% +$409 ﹤0.01% 2788
2022
Q4 		$805K Buy
61,000
+100
+0.2% +$705 ﹤0.01% 2106
2022
Q3 		$180K Buy
60,900
+2,440
+4% +$10.4K ﹤0.01% 3219
2022
Q2 		$213K Buy
58,460
+5,085
+10% +$24.2K ﹤0.01% 3141
2022
Q1 		$330K Buy
53,375
+4,300
+9% +$26.7K ﹤0.01% 2891
2021
Q4 		$397K Buy
49,075
+32,955
+204% +$355K ﹤0.01% 2725
2021
Q3 		$240K Buy
+16,120
New +$201K ﹤0.01% 3117

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commonwealth Equity Services's PDSB Position: Q1 2026 in Review

Commonwealth Equity Services reduced its PDS Biotechnology (PDSB) stake by 54% in Q1 2026, selling an estimated $79.7K and leaving 90,797 shares worth $54.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4195.

Commonwealth Equity Services first reported a position in PDSB in Q3 2021 and has held it in 19 quarters since. The position peaked at $805K in Q4 2022. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Commonwealth Equity Services held 90,797 shares of PDS Biotechnology worth $54.9K as of Q1 2026.
  • Commonwealth Equity Services sold 106,000 PDS Biotechnology shares in Q1 2026, an estimated $79.7K.
  • PDS Biotechnology made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4195 holding.
  • Commonwealth Equity Services first reported a position in PDS Biotechnology in Q3 2021 and has held it in 19 quarters since.
  • Commonwealth Equity Services's PDS Biotechnology position peaked at $805K in Q4 2022.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.